M. Franzè

发表

Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, Liver Cancer International.

Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, European journal of cancer.

Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma.

A. Gasbarrini, F. Piscaglia, R. Golfieri, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis.

G. Raimondo, M. Franzè, C. Saitta, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia

M. Scuruchi, G. Raimondo, M. Franzè, 2022, Biomedicines.

Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity

A. Alibrandi, G. Raimondo, M. Franzè, 2022, Internal and Emergency Medicine.

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis

G. Russo, A. Giandalia, A. Alibrandi, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment

F. Borgia, M. Vaccaro, M. Franzè, 2017, International journal of immunopathology and pharmacology.

Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity

A. Alibrandi, M. Gaeta, G. Raimondo, 2022, Internal and Emergency Medicine.

Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate

A. Alibrandi, G. Raimondo, M. Franzè, 2021, Digestive Diseases and Sciences.

Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance

A. Alibrandi, G. Raimondo, M. Franzè, 2022, Journal of personalized medicine.

Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases

G. Raimondo, M. Franzè, G. Squadrito, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease.

G. Raimondo, M. Franzè, T. Pollicino, 2021, Annals of hepatology.

Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy

A. Alibrandi, G. Raimondo, M. Franzè, 2020, Oncology letters.

Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival.

A. Gasbarrini, M. Zoli, F. Piscaglia, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis

A. Alibrandi, G. Raimondo, M. Franzè, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Natural Course of COVID-19 and Independent Predictors of Mortality

M. Tringali, M. Franzè, G. Squadrito, 2023, Biomedicines.

Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography

A. Alibrandi, G. Raimondo, M. Franzè, 2015, Medicine.

Outcome of cutaneous psoriasis in hepatitis C virus‐infected patients treated with Direct‐Acting Antiviral therapy

A. Alibrandi, C. Guarneri, F. Borgia, 2019, Journal of viral hepatitis.

Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules

A. Alibrandi, G. Raimondo, M. Franzè, 2020, Internal and Emergency Medicine.

Hepatitis Delta Virus and Hepatocellular Carcinoma

M. Franzè, T. Pollicino, Daniele Lombardo, 2024, Pathogens.